WHO approves use of malaria vaccine with adjuvant tech Context The World Health Organization (WHO) on Monday authorized the use of the R21/Matrix-M malaria vaccine, which was created by the Serum Institute of India and the University of Oxford using adjuvant technology from Novavax. The […]
